Clinical Trial Update: Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation

View source ↗

Summary

A completed study evaluating how the Covid-19 context influences strategies for de-escalating rheumatoid arthritis therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University Hospital, Brest | Conditions: Rheumatoid Arthritis, COVID | Status: COMPLETED